|
Volumn 22, Issue 4, 2002, Pages 209-220
|
Therapeutic use of levocloperastine as an antitussive agent: An overview of preclinical data and clinical trials in adults and children
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITUSSIVE AGENT;
CLOPERASTINE;
CODEINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
LEVDROPROPIZINE;
LEVOCLOPERASTINE;
PRIVITUSS;
UNCLASSIFIED DRUG;
AGE;
AROUSAL;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COMPARTMENT MODEL;
COUGHING;
DOSE RESPONSE;
DOSE TIME EFFECT RELATION;
DROWSINESS;
DRUG ABSORPTION;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG TOLERABILITY;
GASTROINTESTINAL SYMPTOM;
HUMAN;
IRRITABILITY;
NAUSEA;
NONHUMAN;
PRIORITY JOURNAL;
RACEMIC MIXTURE;
REVIEW;
SLEEP DISORDER;
TOXICITY TESTING;
XEROSTOMIA;
|
EID: 0036239450
PISSN: 11732563
EISSN: None
Source Type: Journal
DOI: 10.2165/00044011-200222040-00001 Document Type: Review |
Times cited : (14)
|
References (28)
|